MUSL — Promino Nutritional Sciences Balance Sheet
0.000.00%
Last trade - 00:00- CA$0.59m
- CA$1.23m
- CA$0.48m
Annual balance sheet for Promino Nutritional Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.105 | 0.087 | 0.492 | 0.003 | 0.001 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.279 | 0.627 | 0.428 | 0.897 | 0.056 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.8 | 1.13 | 4.92 | 2.56 | 0.134 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.184 | 0.168 | 0.077 | 0.093 | 0.026 |
| Total Assets | 0.983 | 1.3 | 5 | 2.65 | 0.16 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.83 | 3.7 | 3.66 | 7.5 | 6.97 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 3.83 | 3.81 | 3.69 | 7.52 | 8.63 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.85 | -2.5 | 1.3 | -4.87 | -8.47 |
| Total Liabilities & Shareholders' Equity | 0.983 | 1.3 | 5 | 2.65 | 0.16 |
| Total Common Shares Outstanding |